Management of Shiga toxin-associated Escherichia coli-induced haemolytic uraemic syndrome: randomized clinical trials are needed

Lignende værker

• Eculizumab in the treatment of Shiga toxin haemolytic uraemic syndrome
  af: Walsh, Patrick R., et al.
  Udgivet: (2018)
• Haemolytic uraemic syndrome associated with non shiga toxin-producing Escherichia coli bacteraemia: a case report
  af: Bally, Stéphane, et al.
  Udgivet: (2019)
• Haemolytic uraemic syndrome and Shiga toxin-producing Escherichia coli infection in children in France. The Société de Néphrologie Pédiatrique.
  af: Decludt, B., et al.
  Udgivet: (2000)
• Virulence factors of Shiga toxin-producing Escherichia coli and the risk of developing haemolytic uraemic syndrome in Norway, 1992–2013
  af: Naseer, U., et al.
  Udgivet: (2017)
• Shiga toxin-producing Escherichia coli haemolytic uraemic syndrome (STEC-HUS): diagnosis, surveillance and public-health management in England
  af: Jenkins, Claire, et al.
  Udgivet: (2020)